IBB Holdings
iShares Biotechnology ETF
1W: -2.1%
1M: -4.0%
3M: +5.1%
YTD: +21.5%
1Y: +38.4%
3Y: +67.8%
5Y: +21.8%
$205.29
-0.67 (-0.33%)
Weekly Expected Move ±2.9%
$193
$199
$205
$211
$217
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$10.1B
Holdings234
Top 10 Wt49.6%
Beta0.71
% Profitable20%
Coverage100%
Portfolio Valuation
P/E41.3
P/B8.5
P/S7.1
EV/EBITDA28.2
P/FCF23.6
PEG5.44
Profitability & Returns
Gross Margin77.2%
Net Margin10.4%
ROE12.5%
ROA4.9%
ROIC11.0%
Div Yield0.41%
Leverage & Liquidity
Debt/Equity1.02
Debt/Assets0.39
Net Debt/EBITDA1.6x
Interest Cov4.7x
Current Ratio1.91
Quick Ratio1.64
Growth (YoY)
Revenue+30.8%
Net Income+10.2%
EPS+14.0%
FCF+26.3%
EBITDA+11.2%
Rev CAGR 3Y+39.0%
Quality Scores
Piotroski F5.0
Altman Z12.72
IS Quality61.3
IS Overall55.6
IS Value38.8
Median P/E-5.6
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 234 | 99.8% | -7.6 |
| Other | 12 | 0.2% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 0.22% | 3 | Bullish | 1 | 0 | +99.5% |
Showing 50 of 246 holdings
· Page 1 of 5
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES | GILD | 8.24% | $880.9M | 5,787,322 | -55.7 | $179.5B | Healthcare |
| 2 | AMGEN INC | AMGN | 7.71% | $823.3M | 1,968,906 | 24.8 | $217.5B | Healthcare |
| 3 | VERTEX PHARMACEUTICALS | VRTX | 7.68% | $820.4M | 1,554,691 | 29.1 | $128.1B | Healthcare |
| 4 | REGENERON PHARMACEUTICALS | REGN | 5.23% | $558.5M | 742,409 | 17.6 | $75.7B | Healthcare |
| 5 | MODERNA | MRNA | 5.05% | $539.9M | 2,736,646 | -23.8 | $75.4B | Healthcare |
| 6 | NATERA | NTRA | 3.89% | $415.3M | 1,008,539 | -301.7 | $58.8B | Healthcare |
| 7 | ARGENX SE ADR | ARGX | 3.79% | $404.8M | 416,337 | 33.3 | $57.2B | Healthcare |
| 8 | ILLUMINA INC | ILMN | 2.87% | $306.8M | 1,128,175 | 50.5 | $41.3B | Healthcare |
| 9 | REVOLUTION MEDICINES | RVMD | 2.73% | $291.4M | 1,444,207 | -23.3 | $43.9B | Healthcare |
| 10 | ALNYLAM PHARMACEUTICALS | ALNY | 2.39% | $255.2M | 999,216 | 36.0 | $29.4B | Healthcare |
| 11 | BIOGEN | BIIB | 2.35% | $251.2M | 1,098,608 | 38.7 | $32.5B | Healthcare |
| 12 | BEONE MEDICINES AG | ONC | 2.16% | $231.3M | 630,247 | 26.4 | $38.3B | Healthcare |
| 13 | INSMED | INSM | 1.77% | $189.6M | 1,611,524 | -27.0 | $24.1B | Healthcare |
| 14 | INCYTE CORP | INCY | 1.76% | $187.9M | 1,505,337 | 14.2 | $23.4B | Healthcare |
| 15 | UNITED THERAPEUTICS | UTHR | 1.41% | $150.8M | 310,580 | 17.9 | $23.0B | Healthcare |
| 16 | GENMAB SPONSORED ADR | GMAB | 1.37% | $146.8M | 4,150,345 | 26.5 | $21.3B | Healthcare |
| 17 | ROIVANT SCIENCES LTD | ROIV | 1.36% | $145.2M | 3,926,616 | -94.0 | $25.8B | Healthcare |
| 18 | ASCENDIS PHARMA | ASND | 0.99% | $106.3M | 461,903 | 16.7 | $14.2B | Healthcare |
| 19 | NEUROCRINE BIOSCIENCES | NBIX | 0.99% | $105.7M | 752,861 | 20.3 | $14.4B | Healthcare |
| 20 | EXELIXIS INC | EXEL | 0.98% | $104.9M | 1,797,282 | 17.7 | $14.7B | Healthcare |
| 21 | CHARLES RIVER LABORATORIES INTERNA | CRL | 0.98% | $104.2M | 353,674 | -60.0 | $14.0B | Healthcare |
| 22 | MEDPACE HOLDINGS | MEDP | 0.97% | $103.7M | 168,347 | 34.5 | $16.7B | Healthcare |
| 23 | HALOZYME THERAPEUTICS | HALO | 0.89% | $95.0M | 841,207 | 31.2 | $13.0B | Healthcare |
| 24 | BRIDGEBIO PHARMA | BBIO | 0.82% | $87.4M | 1,312,084 | -18.8 | $13.2B | Healthcare |
| 25 | TWIST BIOSCIENCE | TWST | 0.80% | $85.8M | 477,655 | -85.0 | $11.7B | Healthcare |
| 26 | BIOMARIN PHARMACEUTICAL | BMRN | 0.80% | $85.1M | 1,431,420 | 150.5 | $11.1B | Healthcare |
| 27 | BIO TECHNE | TECH | 0.79% | $84.7M | 1,168,517 | 61.9 | $11.3B | Healthcare |
| 28 | MADRIGAL PHARMACEUTICALS | MDGL | 0.78% | $83.3M | 161,198 | -38.7 | $11.5B | Healthcare |
| 29 | REPLIGEN | RGEN | 0.73% | $77.5M | 399,264 | 245.5 | $10.3B | Healthcare |
| 30 | 10X GENOMICS CLASS A | TXG | 0.72% | $76.9M | 868,567 | -158.5 | $11.9B | Healthcare |
| 31 | BIONTECH SE ADR | BNTX | 0.66% | $71.0M | 717,070 | -12.7 | $24.3B | Healthcare |
| 32 | TEMPUS AI CLASS A | TEM | 0.64% | $68.6M | 806,545 | -53.6 | $13.4B | Healthcare |
| 33 | CYTOKINETICS | CYTK | 0.62% | $66.1M | 999,830 | -9.1 | $8.2B | Healthcare |
| 34 | KRYSTAL BIOTECH | KRYS | 0.61% | $65.4M | 194,080 | 39.0 | $9.5B | Healthcare |
| 35 | PROTAGONIST THERAPEUTICS | PTGX | 0.61% | $65.3M | 458,509 | 115.0 | $9.0B | Healthcare |
| 36 | ARROWHEAD PHARMACEUTICALS | ARWR | 0.61% | $65.2M | 996,015 | -28.7 | $9.0B | Healthcare |
| 37 | AXSOME THERAPEUTICS | AXSM | 0.60% | $64.0M | 329,941 | -47.8 | $9.2B | Healthcare |
| 38 | VAXCYTE | PCVX | 0.59% | $63.5M | 1,089,233 | -7.4 | $8.2B | Healthcare |
| 39 | KYMERA THERAPEUTICS | KYMR | 0.59% | $62.6M | 559,328 | -33.0 | $8.8B | Healthcare |
| 40 | PRAXIS PRECISION MEDICINES | PRAX | 0.53% | $56.2M | 196,704 | -22.8 | $8.2B | Healthcare |
| 41 | IONIS PHARMACEUTICALS | IONS | 0.52% | $55.6M | 1,220,659 | -12.6 | $7.2B | Healthcare |
| 42 | ABIVAX AMERICAN DEPOSITARY SHARES | ABVX | 0.49% | $52.7M | 544,397 | -17.7 | $6.8B | Healthcare |
| 43 | BRUKER | BRKR | 0.49% | $52.6M | 831,564 | -90.5 | $9.6B | Healthcare |
| 44 | SPYRE THERAPEUTICS INC | SYRE | 0.48% | $50.8M | 592,000 | -47.8 | $8.1B | Healthcare |
| 45 | ALKERMES | ALKS | 0.46% | $49.0M | 1,219,361 | 103.6 | $7.0B | Healthcare |
| 46 | RHYTHM PHARMACEUTICALS | RYTM | 0.46% | $48.8M | 495,290 | -29.8 | $6.4B | Healthcare |
| 47 | TRAVERE THERAPEUTICS | TVTX | 0.39% | $42.1M | 684,424 | -126.5 | $5.3B | Healthcare |
| 48 | GRAIL INC | GRAL | 0.39% | $41.9M | 315,817 | -14.7 | $6.1B | Healthcare |
| 49 | PTC THERAPEUTICS | PTCT | 0.37% | $39.4M | 597,264 | -129.5 | $5.3B | Healthcare |
| 50 | KODIAK SCIENCES | KOD | 0.37% | $39.2M | 435,574 | -22.5 | $5.9B | Healthcare |